Role and Regulation of Pif1 Family Helicases at the Replication Fork.

Int J Mol Sci

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

Published: March 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Pif1 helicases are a multifunctional family of DNA helicases that are important for many aspects of genomic stability in the nucleus and mitochondria. Pif1 helicases are conserved from bacteria to humans. Pif1 helicases play multiple roles at the replication fork, including promoting replication through many barriers such as G-quadruplex DNA, the rDNA replication fork barrier, tRNA genes, and R-loops. Pif1 helicases also regulate telomerase and promote replication termination, Okazaki fragment maturation, and break-induced replication. This review highlights many of the roles and regulations of Pif1 at the replication fork that promote cellular health and viability.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998199PMC
http://dx.doi.org/10.3390/ijms23073736DOI Listing

Publication Analysis

Top Keywords

replication fork
16
pif1 helicases
16
replication
7
pif1
6
helicases
6
role regulation
4
regulation pif1
4
pif1 family
4
family helicases
4
helicases replication
4

Similar Publications

Acute myeloid leukemia (AML) with rearrangement of the mixed lineage leukemia gene express MLL-AF9 fusion protein, a transcription factor that impairs differentiation and drives expansion of leukemic cells. We report here that the zinc finger protein GFI1 together with the histone methyltransferase LSD1 occupies the promoter and regulates expression of the lncRNA ELDR in the MLL-r AML cell line THP-1. Forced ELDR overexpression enhanced the growth inhibition of an LSD1i/ATRA combination treatment and reduced the capacity of these cells to generate leukemia in xenografts, leading to a longer leukemia-free survival.

View Article and Find Full Text PDF

Nuclease-helicase DNA2 is a multifunctional genome caretaker that is essential for cell proliferation in a range of organisms, from yeast to human. Bi-allelic DNA2 mutations that reduce DNA2 concentrations cause a spectrum of primordial dwarfism disorders, including Seckel and Rothmund-Thomson-related syndromes. By contrast, cancer cells frequently express high concentrations of DNA2 (refs.

View Article and Find Full Text PDF

Replication stress (RS) poses a threat to genome stability and drives genomic rearrangements. The homologous recombination (HR) pathway repairs stalled replication forks (RFs) and prevents such instability. Through an E3 ubiquitin ligase screen aimed at identifying regulators of RAD51, we identified macrophage erythroblast attacher (MAEA), a core component of C-terminal to Lish (CTLH) E3 ubiquitin ligase complex, as a regulator of the HR pathway.

View Article and Find Full Text PDF

Recql5-Deficient Mice as a Model for Studying Chromoanagenesis Phenomena.

Methods Mol Biol

August 2025

Center for Education in Laboratory Animal Research, Chubu University, Kasugai, Aichi, Japan.

Complex chromosomal rearrangements (CCRs) present significant challenges and opportunities in cancer and congenital disease research. Reproducing these rearrangements experimentally in animal models has been challenging, limiting our insights into their mechanisms and impacts. Recql5 is a critical DNA helicase that participates in replication, transcription, and repair processes.

View Article and Find Full Text PDF

PARP inhibitors potentiate proton therapy end-of-range effects by accelerating replication forks and promoting transcription conflict.

Int J Radiat Oncol Biol Phys

August 2025

Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA. Electronic address:

Purpose: Poly ADP ribose polymerase inhibitors (PARPi) are being combined with photon and proton radiotherapy in clinical trials. We sought to investigate mechanisms of PARPi radiosensitization at varying linear energy transfer (LET) levels after observing an extreme normal tissue response in an 18-year-old with high grade glioma without a germline alteration predictive of heightened radiosensitivity treated with veliparib and proton therapy.

Experimental Design: BRCA1/2 wild-type non-cancerous and cancerous cells were treated with PARPi plus photons or protons at the entrance (ENT, dose-averaged LET [LETd] 2.

View Article and Find Full Text PDF